|
Volumn 12, Issue 2, 2007, Pages 37-40
|
Limited predictive value of real-time quantitative PCR cytomegalovirus monitoring in the blood. Fatal CMV pneumonia in an autologous stem cell transplant recipient previously treated with alemtuzumab.
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALEMTUZUMAB;
ANTINEOPLASTIC AGENT;
CANCER ANTIBODY;
MONOCLONAL ANTIBODY;
VIRUS DNA;
ADULT;
ANAPLASTIC LARGE CELL LYMPHOMA;
ARTICLE;
AUTOTRANSPLANTATION;
BLOOD;
CASE REPORT;
CHEMICALLY INDUCED DISORDER;
CYTOMEGALOVIRUS INFECTION;
FATALITY;
FEMALE;
HUMAN;
POLYMERASE CHAIN REACTION;
STEM CELL TRANSPLANTATION;
VIRUS PNEUMONIA;
ADULT;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, NEOPLASM;
ANTINEOPLASTIC AGENTS;
CYTOMEGALOVIRUS INFECTIONS;
DNA, VIRAL;
FATAL OUTCOME;
FEMALE;
HUMANS;
LYMPHOMA, LARGE-CELL, ANAPLASTIC;
PNEUMONIA, VIRAL;
POLYMERASE CHAIN REACTION;
STEM CELL TRANSPLANTATION;
TRANSPLANTATION, AUTOLOGOUS;
|
EID: 39349118198
PISSN: 14259524
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|